P88-22519-42129
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 381 / TN
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Dose 1 — Pfizer-BioNTech
-
2020-12-28
Registered in v-safe
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-09
-
2021-01-16
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Survey response — day 0, dose 2MedDRA: Erythema, Flushing — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessFree text: Flush & red faceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
- 2021-02-07
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-04-17
- 2021-07-17
- 2022-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech |
Free text
Release 2 — day 0, dose 2
Systemic reaction (other): Flush & red face
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release